Moneycontrol PRO
Loans
Loans
HomeNewsIpcalaboratories

Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

Jump to
  • Lupin, Sun Pharma, Dr Reddy's top picks: Arvind Bothra

    Arvind Bothra, vice president of institutional research at Religare Capital Markets says Lupin, Sun Pharmaceutical Industries and Dr Reddy's are top picks in the pharma space.

  • Ipca Laboratories may touch Rs 740: Mayuresh Joshi

    Mayuresh Joshi of Angel Broking feels that Ipca Laboratories may touch Rs 740.

  • Avoid Aurobindo Pharma: Pritesh Mehta

    Pritesh Mehta of IIFL is of the view that one may avoid Aurobindo Pharma.

  • Sell Wockhardt on rally: Mayuresh Joshi

    Mayuresh Joshi of Angel Broking advises selling Wockhardt on rallies.

  • Dhananjay Sinha overweight on IT, pharmaceuticals space

    Dhananjay Sinha of Emkay Global Financial Services is overweight on IT and pharmaceuticals space.

  • Buy Infotech, HCL Tech, Ipca Labs: Nirmal Jain

    Nirmal Jain, chairman of IIFL recommends buying Infotech Enterprises, HCL Technologies, Ipca Laboratories, Torrent Pharma and Dr Reddys Laboratories.

  • Super Six: Top chart picks for October 28

    Tata Steel may see some kind of lower pressure as a breakdown on daily charts as per technicals. So one can take short position in Tata Steel at current market price with a stop loss of Rs 331, expect a target of Rs 307 in the next one-two trading sessions, says Vikrant Jadeja of vibranttrades.com.

  • Buy Ipca Labs, PVR, TVS Motors, Escorts: Sharmila Joshi

    Sharmila Joshi of Peerless Securities recommends buying Ipca Laboratories with a target of Rs 734 and PVR with a target of Rs 513.

  • Bull's Eye: Buy TVS Motor, Tata Global, REC, Canara Bank

    Sharmila Joshi of Peerless Securities advises buying Ipca Laboratories with a target price of Rs 734 and PVR with a target price of Rs 513.

  • Buy Ipca Labs, Crompton Greaves, LIC Housing: D Cunha

    Lancelot D Cunha, CEO of Sharyans Wealth Management recommends buying Ipca Laboratories with a target of Rs 721 and advises selling Housing Development and Infrastructure (HDIL) Futures with a target of Rs 33.35.

  • Bull's Eye: Buy Reliance Power, Titan, LIC Housing, Ipca

    Lancelot D Cunha, CEO of Sharyans Wealth Management Private Limited advised buying Ipca Labs with a target price of Rs 721 and LIC Housing Finance with a target price of Rs 164.

  • 6 stocks likely to see lot of action today

    Aditya Agarwal, Way2Wealth Securities suggests buying Union Bank of India with a target of Rs 118-120 and Ipca Laboratories with a target of Rs 680-720.

  • Super Six: Top chart picks for August 16

    Manas Jaiswal of manasjaiswal.com recommends buying Dish TV India with a target of Rs 52 and NMDC with target of Rs 120.

  • Buy Ipca Labs, target of Rs 700: Sahil Kapoor

    According to Sahil Kapoor of Edelweiss, one can buy Ipca Laboratories at current levels with a target of Rs 700 or even higher.

  • Buy Ipca Laboratories; short JSPL, says Sahil Kapoor

    Sahil Kapoor of Edelweiss recommends buying Ipca Laboratories with a target of Rs 700 and keep a stoploss below Rs 620.

  • Motilal Oswal positive on Wipro, Ipca Laboratories

    Rakesh Tarway Of Motilal Oswal Securities is positive on Wipro and Ipca Laboratories.

  • Buy Ipca Lab, Ashok Leyland, Sun Pharma Adv: Diwan

    Prakash Diwan of Altamount Capital Management recommends buying Sun Pharma Advanced Research Company with a target price of Rs 134.50 and stop loss at Rs 127.50.

  • Bull's Eye: Short HDIL, Reliance Capital; buy Ashok Leyland

    Aashish Tater of Fortunewizard.com advises to short HDIL with a target price of Rs 35 and Jain Irrigation with a target price Rs 46.5.

  • Buy Rasoya Proteins, Welspun Corp, Ipca Lab: Rajesh Agarwal

    Rajesh Agarwal of Eastern Financiers recommends buying Mahindra Ugine Steel Company, Rasoya Proteins, Welspun Corp and Ipca Laboratories.

  • Bull's Eye: Buy Welspun Corp, PTC India; short Sterlite

    Rajesh Agarwal of Eastern Financiers advises to buy Mahindra Ugine for a target price of Rs 95.50 and Rasoya Proteins for a target price of Rs 13.

  • Buy Ipca Labs, target of Rs 730: Manav Chopra

    Manav Chopra, senior technical research analyst at Nirmal Bang Securities recommends a strong buy on Ipca Laboratories with a stop loss of Rs 680.

  • Buy Ipca Laboratories: Sudarshan Sukhani

    One can buy Ipca Laboratories and wait for gains in the next few days, feels Sudarshan Sukhani of s2analytics.com.

  • Short Unitech, Jubilant Foodworks; Long Jet Airways: Jain

    Pankaj Jain of Sunteck Wealthmax advises to short Unitech, Jubilant Foodworks and go long on Jet Airways and Ipca Labs

  • Bull's Eye: Short Sun TV, Jubilant Foods; buy Jet, REC

    Aashish Tater, head of research at fortunewizard.com recommended buying PTC India with a target price of Rs 56 and selling Sun TV Network with a target price of Rs 342.

  • Citi view: How pharma sector is looking post Q4 debacle

    Prashant Nair of Citi India told CNBC-TV18 that the pharma sector's valuations in current market downturn situation has held up well. He presents his views on buzzing stocks from the sector.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347